今海医疗科技股份有限公司（股票代码：02225）于2026年4月1日披露2026年3月股份变动月报表，报告期为2026年3月。
公司公告显示，截至2026年3月31日，法定股本数量为8,000,000,000股，每股面值0.0025港元，法定股本总额20,000,000港元；已发行股份总数为5,290,000,000股，与上月保持一致，当月无新增发行、购回或注销记录。
公司于2023年12月29日采纳的股份期权计划在本月结存数为454,960,000份股份期权，无行权、授出及失效变动。
整体来看，截至报告期末，公司股本结构维持稳定，符合香港联交所的公众持股量要求。该公告由公司秘书黄文耀签署，公司同时确认遵守香港联交所《上市规则》及相关法律规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.